Elona R Rhoda, OT | |
8109 Monroe Ave, Munster, IN 46321-1603 | |
(219) 670-2604 | |
(219) 836-7927 |
Full Name | Elona R Rhoda |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 8109 Monroe Ave, Munster, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295945293 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 31000994 (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Elona R Rhoda, OT 8109 Monroe Ave, Munster, IN 46321-1603 Ph: (219) 670-2604 | Elona R Rhoda, OT 8109 Monroe Ave, Munster, IN 46321-1603 Ph: (219) 670-2604 |
News Archive
Chemspec International Limited, a leading China-based contract manufacturer of highly-engineered specialty chemicals, today announced that its board of directors has authorized a share repurchase program that would allow the Company to repurchase up to US$10 million of its American Depositary Shares ("ADSs") on the open market between September 22, 2010 and September 21, 2011.
Surgical Information Systems ('SIS'), a leader in perioperative information systems, announced today that Mountain States Health Alliance (MSHA) has completed implementation of Perioperative Management by SIS for organizations using Soarian® Clinicals from Siemens Healthcare in two facilities: Johnson City Medical Center and Johnston Memorial Hospital.
Expert clinicians and engineers at the University of Kent are carrying out the first clinical trials of robotic legs for patients
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
› Verified 1 days ago
Judith A Woods, OTR/L,CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1650 45th Ave, Suite 2d, Munster, IN 46321 Phone: 219-836-4921 | |
Northwest Indiana Rehabilitation Services, Inc. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8517 Forest Ave, Munster, IN 46321 Phone: 219-836-1916 Fax: 219-836-4883 | |
Karen Bledsoe, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 Macarthur Blvd, Munster, IN 46321 Phone: 219-703-2061 | |
Mrs. Kaitlyn Marie Frost, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9950 Calumet Ave, Munster, IN 46321 Phone: 219-703-2755 | |
Susan C Degroate, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 Macarthur Blvd, Munster, IN 46321 Phone: 219-703-1404 | |
Mrs. Amy J Smith, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 Macarthur Blvd, Munster, IN 46321 Phone: 219-836-1600 Fax: 219-836-6752 | |
Miss Cathy Marie Mistovich, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 Macarthur Blvd, Munster, IN 46321 Phone: 219-836-2995 Fax: 219-836-4075 |